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Cough syncope is a conspicuous syndrome. Clinically,
the fainting fit is always associated with a paroxysm
of cough, often occurring after a few vigorous coughs.
Cough syncope may result from various etiologies,
such as profound arterial hypotension [1–3], cerebral
hypoperfusion secondary to the corresponding increase
in intracranial pressure [4–6], pulmonary vasocon-
striction and hypoxemia [7], or even reflex cardiac
arrhythmia [8]. Although the syndrome is usually
benign, fatalities have been reported for 1–2% of such
patients [9]. No specific treatment has yet been demon-
strated to be universally effective. The management of
cough syncope can be difficult if individual pathologic
perturbations are not clearly understood, although
there does not appear to be any clear consensus regard-
ing the diagnostic workup for patients suffering from
cough-induced syncope. Coughing is comparable to
an exaggerated valsalva maneuver (VM) because both
conditions elicit an increase in intrathoracic and intra-
cranial pressures and a decrease in venous return [5].
The VM, which elicits hemodynamic responses simi-
lar to those produced by coughing, is a suitable test
for investigating individual pathogenic mechanisms
for patients suffering from cough syncope. However,
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Successful treatment of cough syncope depends on the correction of various pathogenetic mech-
anisms among different patients. The valsalva maneuver (VM), which elicits hemodynamic
responses mimicking coughs, has potential for investigating the individual pathogenesis of
cough syncope. Eighteen consecutive patients suffering from cough-induced syncope were
examined. All patients were asked to cough and to perform VM several times under continuous
cerebral blood-flow velocity and blood pressure (BP) monitoring by transcranial Doppler and
finger plethysmography. Eight patients demonstrated abnormal VM characterized by the absent
BP overshoot following the relief of straining. Patients demonstrating abnormal VM had delayed
BP recovery after cough (median, 16.4; range, 8.7–25.6 seconds) compared to those demonstrating
normal VM (2.6, 1.3–3.8 seconds, p < 0.001). Seven of the 10 patients exhibiting normal BP over-
shoot during VM had stenotic arterial lesions in the cerebral or coronary circulation, whereas
only one of the eight patients demonstrating absent BP overshoot had coronary artery disease
(70% vs. 12.5%, p = 0.025). Other clinical profiles, body mass index, frequency of obstructive pul-
monary disease and valsalva ratio did not differ between patients featuring normal and absent
BP overshoot. In conclusion, the pathogenesis of cough syncope could be different between
patients with normal and abnormal VM responses. Patients who had no BP overshoot during VM
sustained prolonged hypotension after cough. The VM helps in discriminating among pathogenic
mechanisms and guiding investigation and treatment for cough syncope patients.
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VM-induced hemodynamic changes have only been
sparsely investigated in cough syncope patients in the
early literature [5,7]. This study was undertaken to
determine the usefulness of conducting standardized
VM in elucidating the pathophysiologic mechanisms
of cough syncope.
PATIENTS AND METHODS
From January 1998 to June 2002 inclusively, 427 con-
secutive patients suffering from syncope were exam-
ined by an organized team consisting of cardiologists,
neurologists, and experienced sonographers to eval-
uate the cause of syncope systemically. Eighteen male
patients who experienced attacks of only syncope
immediately after coughs were enrolled in this study
prospectively. A detailed medical history was obtained
from all study participants. All participants under-
went detailed physical and neurologic examinations
and blood evaluation including a complete blood cell
count, blood chemical analyses, fasting plasma sugar,
and arterial blood gas analysis. Chest radiography,
spirometry, electrocardiography (ECG), echocardiog-
raphy, awake electroencephalography (EEG), Duplex
ultrasonography of the cervical vessels, and transcra-
nial color-coded sonography were also performed 
in all participants. Significant extracranial or intra-
cranial arterial stenosis was diagnosed according to
the validated ultrasonographic criteria used in our
laboratory. Twenty-four-hour holter ECG and neuro-
imaging studies were performed when clinically
indicated.
Patients abstained from consuming alcohol-, caf-
feine-, or nicotine-containing products for the 10- to
12-hour period prior to undergoing further studies
on hemodynamics. Medication that could interfere
with the testing of autonomic function was also with-
held for at least five half-lives. All measurements were
performed in a temperature-controlled room with
the subjects in the supine position, and were con-
ducted in the morning, at least 2 hours subsequent 
to the patient having eaten a light breakfast. Trans-
cranial Doppler ultrasonography (Multidop X; DWL
Electronische System GmbH, Sipplingen, Germany)
was used to monitor the blood-flow velocity of 
the middle cerebral artery (MCAFV) by using the
usual method. Noninvasive servo-controlled ple-
thysmography (Portapres, TNO-BMI, Amsterdam,
The Netherlands) was used to measure the beat-to-
beat blood pressure (BP).
First, patients were asked to cough forcefully to ob-
tain two similar BP responses. Two reproducible VMs
were performed by blowing into a mouthpiece and
maintaining a pressure of 40 mmHg for a period of 
15 seconds, according to methods described elsewhere
[10,11]. Subsequent to performing VM, all patients
were positioned in a passive, head-up tilt to 70° up-
right position for a period of 30 minutes to rule out the
possibility of neurocardiogenic syncope or postural
hypotension. There was a rest of at least 5 minutes
separating each test. The institutional review board
at this hospital approved the study protocol. All eligi-
ble subjects signed an informed consent form prior to
their being enrolled in the study.
Data analysis
The analog signal of BP and that representing the
peak velocity envelope of MCAFV were fed via an
analog-to-digital converter (BNC2070 and 6020E,
National Instruments, Austin, TX, USA) at a sampling
rate of 200 Hz to an IBM-compatible computer, and
saved on the hard disc for later analysis. Responses to
the VM were divided into four main phases by the
respective maximal and minimal values of BP and
MCAFV as proposed by previous investigators [11–13].
The proportional changes of mean BP and mean
MCAFV during each phase of the VM were estimated
from the baseline values and were used for analytical
purposes. We estimated recovery latencies for both
MCAFV and BP, which Ferrer et al [14] used in 1991
as surrogate markers of autonomic disorder. The time
periods from the trough value for phase III to corre-
sponding baseline value (baseline latency) and the
peak (overshoot latency) of phase IV were calculated
(Figure 1). The time period required for BP to recover
to baseline value after cough was also calculated for
each individual (Figure 1C). The valsalva ratio was
extracted from the maximum heart rate generated by
VM divided by the lowest heart rate occurring within
30 seconds of peak heart rate [10,11].
Continuous data were expressed as median and
range. The χ2 test was used for evaluating categorical
variables, and the Fisher exact test for instances in
which individual counts were < 5. A nonparametric
Mann–Whitney U test was used to compare the dif-
ference between patients featuring a normal and
those who exhibited a delayed BP overshoot.
RESULTS
The clinical profiles of these patients are summarized
in the Table. Eight patients demonstrated an abnor-
mal VM-induced response that was characterized by
absent BP overshoot following the relief of straining
associated with the VM (Figure 1A, left panels). These
patients were classified as group-1 patients. The other
10 patients featuring a normal BP overshoot during
VM were classified as group-2 patients (Figure 1A,
right panels). Age and body mass index were not dif-
ferent between groups (p = 0.725 and 0.705, respec-
tively). Baseline BP value latencies were significantly
prolonged for group-1 patients (8.7, 5.2–18.9 seconds)
compared to group-2 patients (2.6, 1.3–3.8 seconds;
p < 0.001). Group-1 patients had delayed BP recovery
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Figure 1. Characteristic changes in blood pressure (BP) (A, C) and blood-flow velocity of middle cerebral artery (MCAFV; B, D)
induced by the valsalva maneuver (VM; A, B) and by cough (C, D). Horizontal lines indicate periods of straining during VM (A, B) 
or cough (C, D). The left panels demonstrate the absence of BP overshoot during VM in a representative patient from group-1 
patients, and the right panels show corresponding normal responses in a patient from group-2 patients (A). The time required for 
BP to return to baseline levels is prolonged for the group-1 patient following VM and coughing (indicated by “”) as compared to 
its group-2 analog (A, C). Baseline latency (indicated by “*”) and overshoot latencies of MCAFV are similar between the two 
groups (B, D).
after cough (Figure 1C) compared to that of group-2
patients (16.4, 8.7–25.6 seconds vs. 4.3, 3.6–6.4 sec-
onds; p < 0.001). The patterns of BP recovery after
cough were quite similar to that observed after the
relief of straining during VM for each individual
(Figure 1). Doppler flow signals could not be detected
for three patients due to the presence of poor tempo-
ral acoustic windows. The baseline and overshoot
latencies of MCAFV, however, did not differ between
group-1 and group-2 patients, with, respectively,
baseline latencies of 1.8 seconds (1.2–3.6) versus 1.3
seconds (0.9–3.5; p = 0.132) and overshoot latencies 
of 4.1 seconds (2.9–6.1) versus 3.2 seconds (1.7–5.2;
p=0.183). The mean BP values of group-1 patients were
89.6 (60.7–101.5), 105.3 (74.3–126.3), 71.3 (47.7–92.8),
75.5 (47.0–98.3), 29.6 (15.7–50.6), and 82.4 mmHg
(56.7–92.0) for baseline, phase I, phase IIa, phase IIb,
phase III, and phase IV, respectively. The mean BP
values of group-2 patients were 74.7 (61.5–101.5), 93.4
(71.7–168.3), 67.6 (53.8–115.7), 82.8 (58.6–123.3), 54.5
(33.7–99.0), and 93.9 mmHg (70.0–134.7) for the corres-
ponding phases. The proportional changes in mean BP
and mean MCAFV induced by VM are summarized
in Figure 2.
The valsalva ratio was not different between group-1
(1.28, 1.05–1.69) and group-2 patients (1.48, 1.09–1.75;
p = 0.46). None of the studied patients sustained a syn-
cope or presyncope throughout the whole period of
examination. Among all patients, none had significant
abnormality on awake EEG recording. The frequency of
obstructive pulmonary disease as diagnosed by spiro-
metry was 50% for members of both groups. Seven of
the patients from group-2 (70%) exhibited overt cardiac
or cerebral arterial disease(s), and only one patient from
group-1 (12.5%, p = 0.025) had coronary artery disease
diagnosed by coronary angiography.
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Table. Summary of the clinical profiles and medical histories of study patients
Patient/
BMI
Medical
COPD CAD
Holter
Echocardiography Brain imaging
Neurosonology/
age (yr) history ECG tilting table test
Group 1
1/80 24.5 Normal No No Neg Neg Neg Neg
2/73 27.1 HTN Yes No Neg Neg ND Neg
3/80 21.5 Normal Yes No Neg Neg Neg Neg
4/76 22.5 Normal No No Neg Neg Neg Neg
5/80 26.4 Normal Yes No ND Neg Neg Neg, TCD-PW
6/76 22.8 Normal Yes No ND Neg Neg Neg
7/60 29.3 DM No Yes ND 1/3 septal Neg Orthostatic
hypokinesia hypotension
8/45 25.9 Normal No No ND Neg Neg Neg
Group 2
9/76 25.4 HTN No Yes ND LVH R watershed R MCA stenosis
infarct
10/76 24.9 HTN Yes Yes ND Inferior wall Neg Neg
hypokinesia
11/67 22.8 Normal Yes Yes Neg Neg Neg L MCA stenosis
12/79 25.6 Normal Yes Yes ND Neg ND Neg, TCD-PW
13/81 27.5 Normal No No ND Neg Neg Neg
14/74 22.6 HTN No Yes ND Neg Neg Neg
15/69 25.2 DM Yes No ND Neg Neg Neg
16/72 24.2 Normal Yes No ND Neg ND Neg, TCD-PW
17/67 27.4 Normal No No Neg Neg L hemispheric R vertebral, L ICA
infarct stenosis
18/67 28.6 Normal No No Neg Neg Multiple lacunar R ICA stenosis
infarcts
BMI = body mass index; HTN = hypertension; DM = diabetes mellitus; COPD = chronic obstructive pulmonary disease, as demonstrated
by spirometry; CAD = coronary artery disease, as demonstrated by coronary angiography; ECG = electrocardiography; Neg = normal
or negative findings; LVH = left ventricular hypertrophy; ND = not done; R = right; L = left; TCD-PW = poor acoustic windows for
transcranial Doppler; MCA = middle cerebral artery; ICA = internal carotid artery.
DISCUSSION
Our study demonstrated that a certain number of
cough syncope patients revealed an abnormal VM as
characterized by absent BP overshoot after the relief
of straining. The absent BP overshoot was related to
delayed BP recovery after a VM and a cough. Patients
with absent BP overshoot also sustained prolonged
hypotension subsequent to a cough, as illustrated in
Figure 1C. The hypotension after paroxysmal vigor-
ous cough of daily life should be more profound and
cause syncope in patients with absent BP overshoot
during VM. Our findings suggested that VM provided
valuable information about differential hemodynamic
responses among patients with cough syncope.
Absence of BP overshoot in response to VM in
group-1 patient is an uncommon finding. Absence 
of BP overshoot seemed exceptional in healthy el-
derly subjects according to normative data of VM
from a previous study [15]. Absent BP overshoot that
occurs during VM has been presumed to arise as a
consequence of sympathetic adrenergic dysfunction
[10,12,14]. However, the majority of our study patients
revealed no evidence of the presence of any sympa-
thetic failure. Although subtle autonomic dysfunction
cannot be totally excluded by completing a patient’s
Cough syncope and valsalva maneuver
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Figure 2. Percentage changes in: (A) mean blood pressure (BP); and (B) mean blood-flow velocity of the middle cerebral artery
(MCAFV) that occurred during different phases of the valsalva maneuver (VM). Group-1 patients demonstrate absent BP overshoot
during phase IV of VM. Group-2 patients demonstrate normal responses during VM. *p < 0.05; †p < 0.01.
clinical history and by their demonstrating normal BP
responses to passive head-up tilt testing, such subtle
autonomic dysfunction is unlikely to cause absent BP
overshoot during VM [10,12,14].
Previous investigators have described an “emphy-
sema response” characterized by a delay in the occur-
rence of phase IV during VM for patients suffering
from obstructive pulmonary disease [16]. This emphy-
sema response would appear to be similar to the
absent BP overshoot observed in our patients. Zema
et al [17] demonstrated absent overshoot during VM
in eight of 37 patients with chronic obstructive pul-
monary disease. However, the emphysema response
is not related to the severity of pulmonary disease and
could be observed in patients with normal pulmonary
function. Patients with mild congestive heart failure
could have a loss of the overshoot in BP during phase
IV of VM [13,17]. Only two of our 18 patients had
abnormal ventricular wall motion detected by echo-
cardiography. Absence of BP overshoot during VM
should result from complex interactions among sym-
pathetic regulation of cardiac contractibility and vaso-
motor tone, cardiac function, and pulmonary condition.
Additional factors such as the extent of change in
pleural pressure [18,19], low blood volume in alveolar
vessels and intrathoracic cavity [18,20], and cardiac
compression by pulmonary overdistention [21,22]
might also be involved in the absence of BP over-
shoot for group-1 patients.
Patients with delayed BP recovery had a greater
BP reduction during phases IIb and III of VM.
Pulmonary blood volume, which serves as a reser-
voir to maintain left ventricular filling, helps to main-
tain BP during the straining phase of VM [23]. The
greater BP reduction during phase IIb in spite of
compensated tachycardia in group-1 patients might
partly result from decreased pulmonary blood vol-
ume. During phase III of VM, decreased venous
return to left side heart would be accentuated when
intravascular volume decreases [23] and blood vol-
ume in alveolar vessels and intrathoracic cavity is
low [18,19]. The accentuated BP reduction during
phase III in group-1 patients suggested that more
time was required for the increase in venous return 
to circulate through the pulmonary vasculature. The
delayed filling of left side heart turned out to be the
delayed BP recovery in phase IV. Typically, cough
syncope occurs among overweight patients suffering
from chronic pulmonary diseases, and, reportedly,
most often occurs during or soon after a heavy meal
[9]. Cough syncope occurs predominantly in male
[9,24]. Patients with emphysema have lower pul-
monary capillary blood volume [25]. A heavy meal
produces redistribution of more blood in splanchnic
circulation and lower blood volume in pulmonary
circulation. Accordingly, low pulmonary blood volume
should contribute to the occurrence of cough syncope
in group-1 patients.
The valsalva ratio was not different between the
two groups of patients in this study. The greater BP
reduction during straining accentuated sympathetic
activation and cardioacceleration in group-1 patients.
The greater increase in heart rate during the straining
phase resulted in normalization of the valsalva ratio
in group-1 patients, despite there being no reflex bra-
dycardia in the absence of BP overshoot. Previous
investigators also demonstrated that the valsalva ratio
is not a selective test of cardiovagal function [26].
The pathogenesis of cough syncope among patients
featuring normal responses to VM could be different
from that of patients with delayed BP recovery dur-
ing VM. The frequencies of coronary heart disease 
or cerebral arterial stenotic lesions were greater for
group-2 patients than for group-1 patients. The afore-
mentioned arterial stenotic lesions might accentuate
cerebral or cardiac ischemia during coughing for these
so-affected group-2 patients [27]. Elevation of central
venous and intracranial pressures might contribute 
to a marked reduction in cerebral perfusion during
coughing for cough syncope patients who feature a
normal BP overshoot [5,6]. However, our data cannot
be interpreted to address this point. The relative ampli-
tudes and latencies of the MCAFV overshoot did not
differ between our two study groups. Cerebrovascular
autoregulation seemed competent to maintain cere-
bral perfusion for all of our patients despite different
BP responses.
Some limitations of this study should be men-
tioned. First, coughs and VM were performed in the
supine position due to safety considerations. Cough
syncope is less likely to occur in the supine position.
BP reduction during a cough should be greater in the
standing position compared to that in the supine posi-
tion because of more intravascular volume pooling in
lower limbs and more reduction in venous return [28].
Second, we were unable to provide invasive hemo-
dynamic data such as central venous pressure, car-
diac stroke volume or pleural pressure during VM,
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and coughs. Third, our sample size was rather small
given that cough syncope is a relatively uncommon
condition. Further studies among more patients are
warranted prior to the general application of our
results.
In summary, VM may help in discriminating among
pathogenic mechanisms of cough syncope, whereas
it would appear likely that a patient’s physical condi-
tion and medical history would fail to do so. Absence
of BP overshoot during VM suggested that cough
syncope resulted from prolongation of hypotension
after coughs. For such individuals, attempts to keep
adequate intravascular volume, to treat pulmonary
disease, and to avoid heavy meals could help to
reduce or eliminate syncopal attacks during coughing.
On the other hand, patients who exhibited normal BP
responses to VM may need to undergo additional
evaluations to rule out other possible etiologies for
cough syncope, such as stenosis or occlusion of the
cerebral arteries or the presence of some form of
organic heart disease.
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